Efficacy of Rifaximin in Diarrhoea Predominant Irritable Bowel Syndrome: A Placebo Controlled Clinical Trial. Med. Today [Internet]. 2023 Apr. 13 [cited 2026 Jun. 24];35(1):44-8. Available from: https://www.banglajol.info/index.php/MEDTODAY/article/view/64940